
Keywords: OS, osteosarcoma; SEER, Surveillance Epidemiology and End-Results Program of the US National Cancer Institute; MSKCC, Memorial Sloan-Kettering Cancer Center; COG, Children’s Oncology Group; OAS, overall survival; EFS, event-free survival; HDMTX, high-dose